MXPA06012206A - Composicion farmaceutica ozonizada y metodos. - Google Patents

Composicion farmaceutica ozonizada y metodos.

Info

Publication number
MXPA06012206A
MXPA06012206A MXPA06012206A MXPA06012206A MXPA06012206A MX PA06012206 A MXPA06012206 A MX PA06012206A MX PA06012206 A MXPA06012206 A MX PA06012206A MX PA06012206 A MXPA06012206 A MX PA06012206A MX PA06012206 A MXPA06012206 A MX PA06012206A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
ozonidzed
treating
composition
diseases
Prior art date
Application number
MXPA06012206A
Other languages
English (en)
Inventor
Haydee Alba Stenti De Pirillo
Claudia Fernanda Pirillo
Jose Maria Pastoriza
Carlos Alberto Pastoriza
Original Assignee
Haydee Alba Stenti De Pirillo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haydee Alba Stenti De Pirillo filed Critical Haydee Alba Stenti De Pirillo
Publication of MXPA06012206A publication Critical patent/MXPA06012206A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composicion farmaceutica para aplicarse externamente como una preparacion topica para el tratamiento de varias enfermedades, comprendiendo la composicion aceites ozonizados con MSM y sulfoxido de dimetilo (DMSO) para potenciar la penetracion de los principios activos y que permiten el tratamiento de enfermedades internas y externas.
MXPA06012206A 2004-04-20 2005-04-20 Composicion farmaceutica ozonizada y metodos. MXPA06012206A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP040101321A AR051429A1 (es) 2004-04-20 2004-04-20 Composicion farmaceutica ozonizada y metodos para obtenerla
PCT/US2005/013223 WO2005117913A2 (en) 2004-04-20 2005-04-20 Ozonized pharmaceutical composition and method

Publications (1)

Publication Number Publication Date
MXPA06012206A true MXPA06012206A (es) 2007-05-16

Family

ID=37461286

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06012206A MXPA06012206A (es) 2004-04-20 2005-04-20 Composicion farmaceutica ozonizada y metodos.

Country Status (9)

Country Link
US (1) US20070254963A1 (es)
EP (1) EP1765373A4 (es)
AR (1) AR051429A1 (es)
AU (1) AU2005249370B2 (es)
BR (1) BRPI0509989A2 (es)
CA (1) CA2563697A1 (es)
MX (1) MXPA06012206A (es)
NZ (1) NZ550671A (es)
WO (1) WO2005117913A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
ITBS20070178A1 (it) * 2007-11-15 2009-05-16 Paoli Ambrosi Gianfranco De Composizione per uso farmaceutico e/o cosmetico e/o in forma di dispositivo medico per favorire processi di cicatrizzazione, per il trattamento di cicatrici ipertrofiche e per migliorare le proprieta' biomeccaniche della cute
JP5947721B2 (ja) 2009-10-30 2016-07-06 アベラ ファーマスーティカルズ インコーポレイテッド 変形性関節症を治療するためのジメチルスルホキシド（ｄｍｓｏ）およびメチルスルホニルメタン（ｍｓｍ）製剤
ITMI20110354A1 (it) * 2011-03-07 2012-09-08 Neovalis S R L Composizione a base di olio ozonizzato per uso topico
DE102011013920A1 (de) * 2011-03-14 2012-09-20 Wolfgang Winkelmann Medizinische Hautabdeckung zur Behandlung von Infektionen der Haut
DE102012007239A1 (de) * 2012-04-10 2013-10-10 Wolfgang Winkelmann Pharmazeutische Zusammensetzung enthaltend eine mit Sauerstoff angereicherte ungesättigte Fettsäure und ein organisches Lösungsmittel
DE102015001289A1 (de) * 2015-01-29 2016-08-04 Wolfgang Winkelmann Pharmazeutische Zusammensetzungen und Pflanzenschutzmittel enthaltend mit Sauerstoff angereicherte Pflanzenöle oder Fettsäuren
RU2627465C2 (ru) * 2015-09-30 2017-08-08 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт фтизиопульмонологии" Министерства здравоохранения Российской Федерации (ФГБУ "УНИИФ" Минздрава России) Способ обработки костной полости после некрсеквестрэктомии

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477469A (en) * 1979-08-30 1984-10-16 Herschler R J Preparations containing methylsulfonylmethane and methods of use and purification
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
US4451480A (en) * 1982-04-16 1984-05-29 James Howard Brown Method of treating acne using ozonized materials
US4591602A (en) * 1982-04-16 1986-05-27 James H. Brown Ozonide esters and topical compositions containing same
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US6663874B2 (en) * 1998-11-02 2003-12-16 Victor Stevens Composition to alleviate pain and topical method of applying same
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20050192267A1 (en) * 2004-02-20 2005-09-01 Hofmann Robert F. Use of targeted oxidative therapeutic formulation in treatment of viral diseases

Also Published As

Publication number Publication date
BRPI0509989A2 (pt) 2012-05-29
EP1765373A4 (en) 2011-01-19
US20070254963A1 (en) 2007-11-01
CA2563697A1 (en) 2005-12-15
AR051429A1 (es) 2007-01-17
NZ550671A (en) 2009-06-26
AU2005249370B2 (en) 2010-10-28
EP1765373A2 (en) 2007-03-28
AU2005249370A1 (en) 2005-12-15
WO2005117913A2 (en) 2005-12-15
WO2005117913A3 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
SG155188A1 (en) Pyrrole derivatives as pharmaceutical agents
WO2009109618A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
MX2009008166A (es) Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
WO2009109616A8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
HK1127289A1 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol
MY158428A (en) Topical composition for the treatment of actinic keratosis
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
GB2456475A (en) Composition for the treatment of skin conditions
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
TNSN08506A1 (en) Substituted carboxamides
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
WO2008051527A3 (en) Sustained release of agents for localized pain management
WO2006136428A3 (en) Method and composition to treat skin ulcers
WO2009122404A3 (en) Device for in situ production and topical administration of allicin
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
WO2007009147A3 (de) Homogemcitabine
WO2007133749A3 (en) Methods and compositions for treating and preventing peripheral nerve damage
WO2007144889A3 (en) Treatment of neurofibromatosis
WO2006060736A3 (en) A composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug

Legal Events

Date Code Title Description
FA Abandonment or withdrawal